Panafrican News Agency (Dakar) - March 29, 2001
The ACDP was reacting to explanations Wednesday in Parliament by Dr Helen Rees of the Medicines Council, that the anti-AIDS drug was being withheld because babies may be re- infected in the future or die of common childhood illnesses such as diarrhoea.
She said for these reasons, packaging must still be worked on and that until such a time, the Medicines Control Council cannot register Nevirapin and it may not be dispensed.
Countering the postulation that a child may develop resistance to Nevirapin, ACDP spokesperson Liza Lambert argued that "the child is likely to be dead if it does not receive Nevirapin and future resistance would be a non-issue," adding that HIV-mothers should at least be given an option.
She further observed that "Mysoprostal, on the other hand, which can cause haemorrhaging and even death in mothers, is being dispensed as an abortifant not only by practitioners, but also by the State, despite the drug not being registered with the Medicines Control Council for such purposes."
She then appealed to the Health Department to make Nevirapin available to HIV-mothers in order to save lives.
010329
PA010343
Copyright © 2001 - Panafrican News Agency. For information about the content or for permission to redistribute, publish or use for broadcast, contact the publisher: The Panafrican News Agency B.P. 4056, Dakar, Senegal. Tel: (221) 824-13-95 Fax: (221) 824-13-90 E-mail: quoiset@sonatel.senet.net.
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1990, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Feedback/Contact Us.